- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin and metabolic diseases: a focus on hepatic aspects
Authors
Keywords
metformin, diabetes, hepatic steatosis, inflammatory response, insulin resistance
Journal
Frontiers of Medicine
Volume 9, Issue 2, Pages 173-186
Publisher
Springer Nature
Online
2015-02-13
DOI
10.1007/s11684-015-0384-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Efficacy of Metformin in Patients With Type 2 Diabetes Mellitus and Chronic Hepatitis C
- (2014) Kira Harris et al. ANNALS OF PHARMACOTHERAPY
- AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease
- (2014) D. Grahame Hardie JOURNAL OF INTERNAL MEDICINE
- Berberine and Its Metabolites: Relationship between Physicochemical Properties and Plasma Levels after Administration to Human Subjects
- (2014) Silvia Spinozzi et al. JOURNAL OF NATURAL PRODUCTS
- Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity
- (2014) Shih-Lung Woo et al. PLoS One
- Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats
- (2014) Yueshan Hu et al. PLoS One
- Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes
- (2013) Gabriela Prutsky et al. ANNALS OF INTERNAL MEDICINE
- Randomized, Vitamin E-Controlled Trial of Bicyclol Plus Metformin in Non-Alcoholic Fatty Liver Disease Patients with Impaired Fasting Glucose
- (2013) Ying Han et al. CLINICAL DRUG INVESTIGATION
- Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy
- (2013) S. Vecchio et al. CLINICAL TOXICOLOGY
- The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
- (2013) Hanford Yau et al. Current Diabetes Reports
- Pharmacogenetic Variation and Metformin Response
- (2013) Suning Chen et al. CURRENT DRUG METABOLISM
- 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: Established knowledge and evidence gaps
- (2013) Francesco Paneni Diabetes & Vascular Disease Research
- Molecular mechanism of action of metformin: old or new insights?
- (2013) Graham Rena et al. DIABETOLOGIA
- Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats
- (2013) C Y Shan et al. JOURNAL OF ENDOCRINOLOGY
- Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells
- (2013) Y.-H. Xun et al. JOURNAL OF VIRAL HEPATITIS
- Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review
- (2013) Maria-Elena Lautatzis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase
- (2013) Wenguang Chang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Metformin trims fats to restore insulin sensitivity
- (2013) Reuben J Shaw NATURE MEDICINE
- Metformin improves healthspan and lifespan in mice
- (2013) Alejandro Martin-Montalvo et al. Nature Communications
- Metformin: an old but still the best treatment for type 2 diabetes
- (2013) Lilian Beatriz Aguayo Rojas et al. Diabetology & Metabolic Syndrome
- Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes?
- (2013) Ronald CW Ma Lancet Diabetes & Endocrinology
- A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells
- (2012) Lauren E. Nelson et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Berberine: New perspectives for old remedies
- (2012) Micol Tillhon et al. BIOCHEMICAL PHARMACOLOGY
- Metformin affects the circadian clock and metabolic rhythms in a tissue-specific manner
- (2012) Maayan Barnea et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma
- (2012) Qingqiong Luo et al. BMC CANCER
- Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
- (2012) K. Bhalla et al. Cancer Prevention Research
- Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?
- (2012) Marina Shargorodsky et al. Cardiovascular Diabetology
- Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: A randomized clinical trial
- (2012) Alireza Esteghamati et al. CLINICAL NUTRITION
- Metformin-Induced Hepatotoxicity
- (2012) F. Miralles-Linares et al. DIABETES CARE
- Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
- (2012) DIABETES CARE
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETOLOGIA
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
- (2012) G. Musso et al. DIABETOLOGIA
- Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis
- (2012) Hui Dong et al. Evidence-based Complementary and Alternative Medicine
- Thiazolidinedione safety
- (2012) Jacqueline Kung et al. Expert Opinion On Drug Safety
- Nonalcoholic fatty liver disease (NAFLD): Is it really a serious condition?
- (2012) Julia Wattacheril et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Targeted Overexpression of Inducible 6-Phosphofructo-2-kinase in Adipose Tissue Increases Fat Deposition but Protects against Diet-induced Insulin Resistance and Inflammatory Responses
- (2012) Yuqing Huo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Palmitoleate Induces Hepatic Steatosis but Suppresses Liver Inflammatory Response in Mice
- (2012) Xin Guo et al. PLoS One
- Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
- (2012) Yuki Kita et al. PLoS One
- Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
- (2012) Arian Emami Riedmaier et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register
- (2012) Nils Ekström et al. BMJ Open
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Restoration of autophagy by puerarin in ethanol-treated hepatocytes via the activation of AMP-activated protein kinase
- (2011) Byung-Kyu Noh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
- (2011) Yu Li et al. Cell Metabolism
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice
- (2011) P. W. Caton et al. DIABETES OBESITY & METABOLISM
- The Role of Metformin in the Management of NAFLD
- (2011) Angela Mazza et al. Experimental Diabetes Research
- AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
- (2011) Antero Salminen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
- (2011) Xuan Xia et al. PLoS One
- Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis
- (2010) M. O. Rakoski et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse
- (2010) Daniel Da Silva et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Thiazolidinedione Drugs and Cardiovascular Risks
- (2010) Sanjay Kaul et al. CIRCULATION
- Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats
- (2010) Daniel A. Kane et al. FREE RADICAL BIOLOGY AND MEDICINE
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
- (2010) G A Garinis et al. INTERNATIONAL JOURNAL OF OBESITY
- Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
- (2010) Jiangyong Ouyang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of hepatic metabolism by AMPK
- (2010) Marc Foretz et al. JOURNAL OF HEPATOLOGY
- Clarifying metformin's role and risks in liver dysfunction
- (2010) Carolyn C. Brackett JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
- (2010) Valter Donadon et al. LIVER INTERNATIONAL
- Effects of metformin on glucose metabolism of perfused rat livers
- (2010) Francielli Maria de Souza Silva et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein
- (2009) Ling He et al. CELL
- Immature myeloid cells induced by a high-fat diet contribute to liver inflammation
- (2009) Zhong-bin Deng et al. HEPATOLOGY
- Hepatic Autophagy Is Suppressed in the Presence of Insulin Resistance and Hyperinsulinemia
- (2009) Hui-Yu Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor
- (2009) Marta Paiva et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Berberine improves free-fatty-acid–induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator–activated receptor γ and fatty acid transferase expressions
- (2009) Yanfeng Chen et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
- (2009) Hao Zhang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
- (2008) Xu Huang et al. BIOCHEMICAL JOURNAL
- Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I: A Mechanism for the Action of Berberine to Activate AMP-Activated Protein Kinase and Improve Insulin Action
- (2008) N. Turner et al. DIABETES
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-α Signaling through IKK2
- (2008) Jin Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
- (2008) Wei-Jia Kong et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Polymorphism in human organic cation transporters and metformin action
- (2008) Hiroshi Takane et al. PHARMACOGENOMICS
- AMPK: a metabolic gauge regulating whole-body energy homeostasis
- (2008) Ricardo Lage et al. TRENDS IN MOLECULAR MEDICINE
- Berberine improves glucose metabolism through induction of glycolysis
- (2007) Jun Yin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?
- (2007) R. E. Buckingham et al. DIABETES OBESITY & METABOLISM
- Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease
- (2007) Elisa Fabbrini et al. GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now